Treatment of urge incontinence in Veterans Affairs medical centers

Clinical Therapeutics

Volumn 21, Issue 5, 1999, Pages 867-877

  Malone, Daniel C ^a   Okano, Gary J ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b Strategic Outcomes Services Inc   (United States)

Author keywords

Department of Veterans Affairs medical center; Dicyclomine; Imipramine; Oxybutynin; Urge incontinence

Indexed keywords

DICYCLOVERINE; FLAVOXATE; HYOSCYAMINE; IMIPRAMINE; OXYBUTYNIN; PROPANTHELINE BROMIDE; PSEUDOEPHEDRINE;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; DRUG CHOICE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRESCRIPTION; PREVALENCE; SOLDIER; URGE INCONTINENCE;

EID: 0033005421     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(99)80008-3     Document Type: Article

References (15)

1. 1. National Institutes of Health Consensus Development Conference. Urinary incontinence in adults, J Am Geriatr Soc. 1990; 38:265-272.
2. 2. Ouslander JG. Urinary incontinence in nursing homes. J Am Geriatr Soc. 1990; 38:289-291.
3. 3. Wyman JF, Harkins SW, Fantl JA. Psychological impact of urinary incontinence in the community-dwelling population. J Am Geriatr Soc. 1990;38:282-288.
4. 4. Fantl JA, Newman DK, Colling J, et al. Urinary Incontinence in Adults: Acute and Chronic Management. Clinical Practice Guidelines, No. 2, 1996 Update. Rockville, Md: US Agency for Health Care Policy and Research Publication No. 96-0682; March 1996.
5. 5. Rousseau P, Fuentevilla-Clifton A. Urinary incontinence in the aged. Part I: Patient evaluation. Geriatrics. 1992;47:22-34.
6. 6. Hampel C, Weinhold D, Benken N, et al. Definition of overactive bladder and epidemiology of urinary incontinence. Urology. 1997;50(Suppl 6A):4-14.
7. 7. Thom D. Variation in estimates of urinary incontinence prevalence in the community: Effects of definition, population characteristics, and study type. J Am Geriatr Soc. 1998;46:473-480.
8. 8. Carter BL, Malone DC, Valuck RJ, et al. The IMPROVE Study: Background and study design. Am J Health-Syst Pharm. 1998:55:62-67.
9. 9. AHFS 98 Drug Information. Bethesda, Md: American Society of Health-Systems Pharmacists, Inc; 1998.
10. 10. Drug Facts and Comparisons, January 1998. St. Louis, Mo: Facts and Comparisons; 1998.
11. 11. Malone DC, Billups SJ, Valuck RJ, Carter BL. Development of a chronic disease indicator score using a Veterans Affairs medical center medication database. J Clin Epidemiol. In press.
12. 12. Milner G, Hills NF. A double-blind assessment of antidepressants in the treatment of 212 enuretic patients. Med J Aust. 1968:1:943-947.
13. 13. Castleden NS, Duffin HM, Gulati RS. Double-blind study of imipramine and placebo for incontinence due to bladder instability. Age Ageing. 1986;15:299-303.
14. 14. Karram MM, Bhatia NN. Management of coexistent stress and urge urinary incontinence. Obstet Gynecol. 1989;73:4-7.
15. 15. Appell RA. Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: A pooled analysis. Urology. 1997; 50(Suppl 6A):90-96.